Skip to content
Search:
Search
Facebook page opens in new window
 
ADCS
Alzheimer's Disease Cooperative Study
ADCSADCS
  • About Us
    • About ADCS
    • Meet the Team
    • ADCS Cores
    • ADCS Site Network
    • Intervention Selection Committee (ISC)
    • ADCS Steering Committee
  • Public & Participant Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Clinical Sites
    • Types of Studies
    • Participate in Research
    • Lifestyle Interventions
    • Alzheimer’s Study Quilt Project
    • DONATE
  • Investigator Resources
    • Publications
    • Study Resources
    • Data Sharing
    • Biorepository
    • ADCS Instruments
    • Preliminary Proposals
    • Combination Therapy Call OPEN
  • Steering Committee Members
  • Staff Resources
  • About Us
    • About ADCS
    • Meet the Team
    • ADCS Cores
    • ADCS Site Network
    • Intervention Selection Committee (ISC)
    • ADCS Steering Committee
  • Public & Participant Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Clinical Sites
    • Types of Studies
    • Participate in Research
    • Lifestyle Interventions
    • Alzheimer’s Study Quilt Project
    • DONATE
  • Investigator Resources
    • Publications
    • Study Resources
    • Data Sharing
    • Biorepository
    • ADCS Instruments
    • Preliminary Proposals
    • Combination Therapy Call OPEN
  • Steering Committee Members
  • Staff Resources

Daily Archives: September 10, 2014

You are here:
  1. Home
  2. 2014
  3. September
  4. 10

A new study published in the British Medical Journal finds that anti-anxiety drugs may increase the risk of Alzheimer’s.

Research NewsBy ADCS AdminSeptember 10, 2014

The drugs have been associated with short-term cognitive impairment, but the connection to Alzheimer’s has been less clear. Now, the new study finds a convincing, and apparently strong, link between benzodiazepines and Alzheimer’s disease.

Copyright 2017 Regents of the University of California.
Go to Top